A Randomized, Controlled Trial to Investigate the Efficacy of Nebulized Poractant Alfa in Premature Babies with Respiratory Distress Syndrome

To investigate the efficacy and safety of nebulized poractant alfa (at 200 and 400 mg/kg doses) delivered in combination with nasal continuous positive airway pressure compared with nasal continuous positive airway pressure alone in premature infants with diagnosed respiratory distress syndrome.

Gespeichert in:
Autor*in:

Dani, Carlo [verfasserIn]

Talosi, Gyula

Piccinno, Annalisa

Ginocchio, Virginia Maria

Balla, Gyorgy

Lavizzari, Anna

Stranak, Zbynek

Gitto, Eloisa

Martinelli, Stefano

Plavka, Richard

Krolak-Olejnik, Barbara

Lista, Gianluca

Spedicato, Francesca

Ciurlia, Giorgia

Santoro, Debora

Sweet, David

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2022

Schlagwörter:

respiratory distress syndrome

nebulized surfactant

poractant alfa

aerosol delivery

vibrating-membrane nebulizer

investigational eFlow Neos nebulizer

Umfang:

436

Übergeordnetes Werk:

Enthalten in: Media usage diminishes memory for experiences - Tamir, Diana I. ELSEVIER, 2018, St. Louis, Mo

Übergeordnetes Werk:

volume:246 ; year:2022 ; pages:40-475 ; extent:436

Links:

Volltext

DOI / URN:

10.1016/j.jpeds.2022.02.054

Katalog-ID:

ELV058240209

Nicht das Richtige dabei?

Schreiben Sie uns!